These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Chemotherapy of malignant gliomas. Krauseneck P; Müller B Recent Results Cancer Res; 1994; 135():135-47. PubMed ID: 7519355 [No Abstract] [Full Text] [Related]
5. [Chemotherapy of brain tumors in children]. Chastagner P; Olive-Sommelet D Arch Fr Pediatr; 1990 Feb; 47(2):147-54. PubMed ID: 2183741 [TBL] [Abstract][Full Text] [Related]
6. [Systemic therapies administration for adult patients in neuro-oncology: The standards of the Association of the neuro-oncologists of French expression (ANOCEF)]. Simon N; Vasseur M; Chauffert B; Taillandier L; Le Rhun E Bull Cancer; 2016 Apr; 103(4):400-1. PubMed ID: 26874975 [No Abstract] [Full Text] [Related]
7. [Chemotherapy of tumors of the central nervous system]. Hildebrand J Rev Med Brux; 1987 Apr; 8(4):195-8. PubMed ID: 3589267 [No Abstract] [Full Text] [Related]
8. Chemotherapy for malignant brain tumors of astrocytic and oligodendroglial lineage. Hofer S; Herrmann R J Cancer Res Clin Oncol; 2001 Feb; 127(2):91-5. PubMed ID: 11216919 [TBL] [Abstract][Full Text] [Related]
10. Does chemotherapy benefit the patient with a central nervous system glioma? Rodriguez LA; Levin VA Oncology (Williston Park); 1987 Nov; 1(9):29-36, 40-1. PubMed ID: 3079493 [TBL] [Abstract][Full Text] [Related]
11. CCNU overdose during PCV chemotherapy for anaplastic astrocytoma. Abele M; Leonhardt M; Dichgans J; Weller M J Neurol; 1998 Apr; 245(4):236-8. PubMed ID: 9591226 [No Abstract] [Full Text] [Related]
12. Brain tumors in children: current cooperative and institutional chemotherapy trials in newly diagnosed and recurrent disease. Allen JC; Bloom J; Ertel I; Evans A; Hammond D; Jones H; Levin V; Jenkin D; Sposto R; Wara W Semin Oncol; 1986 Mar; 13(1):110-22. PubMed ID: 3513315 [No Abstract] [Full Text] [Related]
16. Long-term survival of a patient with metastatic melanoma treated with nivolumab and vemurafenib, with the development of vitiligo. Fukumoto T; Fujiwara S; Sakaguchi M; Oka M; Kiyota N; Ejima Y; Nakajima K; Nishigori C Eur J Dermatol; 2017 Apr; 27(2):177-178. PubMed ID: 27873735 [No Abstract] [Full Text] [Related]
17. [Chemotherapy of brain tumors: biological basis of its limited efficacy]. Mousseau M Bull Cancer; 1994 May; 81(5):414-24. PubMed ID: 7749219 [TBL] [Abstract][Full Text] [Related]
18. The Blood Brain Barrier and BRAF inhibitors: Implications for patients with melanoma brain metastases. Smalley KSM; Forsyth PA Pharmacol Res; 2018 Sep; 135():265-267. PubMed ID: 29146209 [No Abstract] [Full Text] [Related]
19. Rapid regression of metastatic brain tumours in a melanoma patient after dabrafenib/trametinib therapy. Komori T; Otsuka A; Kusuba N; Taniguchi K; Endo Y; Honda T; Kabashima K Eur J Dermatol; 2017 Oct; 27(5):548-549. PubMed ID: 29084644 [No Abstract] [Full Text] [Related]
20. The intraarterial route of drug delivery in the chemotherapy of malignant brain tumours. Loew F; Papavero L Adv Tech Stand Neurosurg; 1988; 16():51-79. PubMed ID: 3064756 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]